Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL [Phase 1]
Phase 1 study of TAA-specific cytotoxic T lymphocytes (TACTAL) for Hodgkin lymphoma and non-Hodgkin lymphoma; the trial is currently active …
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies [Phase 1]
Phase 1 study evaluating CD19/CD22 CAR T cells in children and young adults with recurrent or refractory CD19/CD22-expressing B cell maligna…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 [EARLY_Phase 1]
A clinical trial update shows STR-P004 for Non-Hodgkin lymphoma is in early Phase 1 and not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers [Phase 1, Phase 2]
A clinical trial update indicates IDP-023 is being studied as a single agent and in combination with antibody therapies in advanced hematolo…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Study of 3D189 in Patients With Hematologic Malignancies [Phase 1]
Phase 1 study of 3D189 in hematologic malignancies is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating the CAR-T therapy C-CAR039 in relapsed/refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic CD19-targeting CAR-T cells with SPPL3 gene knockout for relapsed/refractory B-cell lymphoma…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TRAC and SPPL3 gene-knockout allogeneic CD19-targeting CAR-T cells for relapsed/refractory B-cell non-…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects [Phase 1]
A Phase 1 study evaluating the safety and efficacy of the CAR-T therapy C-CAR039 in patients with Non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]
This update notes the completion of a Phase 1 study evaluating C-CAR039 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
A prospective cohort study on lymphoma sponsored by Samsung Medical Center is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas [Phase 1]
MIL62 was studied in a Phase 1 trial for CD20-positive B-cell non-Hodgkin lymphoma; the study has completed.
-
CLINICAL_TRIALS other · 2025-05-16Clinical Trial Update: Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial evaluating Genetically Engineered Anti-CD19/CD20/CD22 CAR T-cells for relapsed or refractory lymphoid malignancies; c…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas [Phase 1]
Phase 1 clinical trial update evaluating administration of T lymphocytes to prevent relapse in Hodgkin lymphoma and other lymphomas; results…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]
Phase 1 study assessing feasibility and safety of UCD19 CD19-directed CAR T cells in adults with relapsed/refractory B-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 trial evaluated a conditioning regimen incorporating venetoclax, carmustine, etoposide, cytarabine, and melphalan before stem ce…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: GVM±R in Patients With Relapsed or Refractory Aggressive NHL [Phase 1]
A Phase 1 trial of GVM±R in relapsed or refractory aggressive non-Hodgkin lymphoma is active but not currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab [Phase 1]
A Phase 1 clinical trial is investigating prophylaxis and treatment of cytokine release syndrome with siltuximab prior to epcoritamab in non…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy [NA]
Clinical trial update on evaluating comprehensive geriatric assessment to predict toxic events in older patients with Non-Hodgkin lymphoma, …
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity [Phase 2]
Phase 2 trial evaluating anakinra to prevent CAR-T cell–mediated neurotoxicity in Non-Hodgkin lymphoma; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study of CPI-613 (devimistat) in combination with bendamustine for relapsed/refractory T-cell non-Hodgkin lymphoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial of lenalidomide plus rituximab for Non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation [Phase 2]
Phase 2 trial evaluating tocilizumab to prevent graft-versus-host disease after cord blood transplantation has been completed.